Image

Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive Dermatomyositis

Recruiting
18 years of age
Both
Phase 4
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

We conduct this study to investigate the efficacy of triple therapy (high-dose glucocorticoids + cyclophosphamide + calcineurin inhibitor) compared with dual-therapy regimens (high-dose glucocorticoids + cyclophosphamide/calcineurin inhibitor) and whether it reduces the risk of poor pulmonary prognosis in patients with moderate to high risk anti-MDA5+ DM.

Eligibility

Inclusion Criteria:

  • Adult patients meet the diagnostic criteria for dermatomyositis of Bohan and Peter
  • Anti-MDA5 Antibody-positive

Exclusion Criteria:

  • Complicated with other connective tissue diseases
  • Complicated with cardiovascular and respiratory disease caused by other reasons
  • Interstitial lung disease caused by environment and drugs
  • Patients with key research missing data or without informed consent

Study details

Dermatomyositis, Adult Type, Interstitial Lung Disease

NCT05375435

The First Affiliated Hospital with Nanjing Medical University

26 January 2024

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.